&w=3840&q=100)
Vodafone Idea share price rises after company launches 5G in Bengaluru
At 9:38 AM, Vi shares were trading 1.87 per cent higher at ₹7.1 per share on the BSE. In comparison, the BSE Sensex was up 0.13 per cent at 82,495.09. The company's market capitalisation stood at ₹76,815.21 crore. Its 52-week high was at ₹19.15 per share and 52-week low was at ₹6.46 per share.
Vodafone Idea's 5G launch details
Vi (Vodafone Idea) announced the launch of its 5G services in Bengaluru starting today.
With this launch, according to the company filing, residents and businesses in India's tech hub can have faster data speeds, lower latency, and enhanced connectivity.
This rollout follows Vi's recent 5G launches in Mumbai, Delhi-NCR, Patna and Chandigarh, and is part of the company's strategic rollout in all 17 priority circles, where it has acquired 5G spectrum, by August this year.
As an introductory offer, Vi is providing unlimited 5G data to users on plans starting from ₹299.
"We're excited to bring Vi 5G to Bengaluru, a city that stands at the forefront of tech and digital innovation. With our next-gen 5G and enhanced 4G network, we aim to deliver enhanced experience to our users. Encouraged by the strong response and robust performance in our launched markets, we are committed to expanding our 5G footprint in line with growing demand and 5G handset adoption," said Anand Dani, business head - Karnataka, Vodafone Idea.
Further, Vi has partnered with Samsung to deploy advanced, energy-efficient infrastructure and implemented Al-powered Self-Organising Networks (SON) to automatically optimise network performance.
About Vodafone Idea
Vodafone Idea is an Aditya Birla Group and Vodafone Group partnership. It is amongst India's leading telecom service providers. The company provides pan India Voice and Data services across 2G and 4G technology. The company holds a large spectrum portfolio including mid-band 5G spectrum in 17 circles and mmWave spectrum in 16 circles and is in the process of launching 5G in 17 circles. The company is developing infrastructure to introduce newer and smarter technologies, making both retail and enterprise customers future ready with innovative offerings, conveniently accessible through an ecosystem of digital channels as well as extensive on-ground presence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
23 minutes ago
- Mint
Sun Pharma shares fall 5.7% post Q1 results: What should investors do now?
Sun Pharmaceutical Industries saw its shares tumble by 5.7 percent to an intraday low of ₹ 1,608.30 on the BSE on Friday, following the announcement of its first-quarter results for FY26. The stock's decline was largely triggered by a sharp 20 percent year-on-year fall in consolidated net profit to ₹ 2,278 crore for the June 2025 quarter, compared to ₹ 2,836 crore in the same quarter last year. On a sequential basis, however, net profit rose 6 percent from ₹ 2,150 crore reported in the March 2025 quarter. Adding to the negative sentiment was the fact that several brokerages revised their target prices downward for the pharma major. Despite the profit drop, Sun Pharma posted a healthy top-line performance. The consolidated revenue grew over 9 percent year-on-year to ₹ 13,851 crore, driven by solid momentum across its key markets—including India, the US, and Rest of World (ROW) geographies. EBITDA rose by 19.2 percent to ₹ 4,302 crore, with margins expanding to 31.1 percent from 28.5 percent in the same period last year. Commenting on the performance, Dilip Shanghvi, Chairman and Managing Director of Sun Pharma, said the company delivered a strong quarter with consistent growth across markets. 'India continues to show strong momentum, contributing meaningfully to the overall performance. The U.S. launch of LEQSELVI is a significant milestone, expanding our dermatology portfolio and strengthening our Innovative Medicines business,' he said. Brokerages React: Trimming Targets, Watching Specialty Growth HDFC Securities lowered its FY26 and FY27 EPS estimates by 7 percent and 6 percent respectively and cut the target price to ₹ 1,960, valuing the stock at 33x Q1FY28E EPS. While it expects strong momentum in the specialty segment—including a ramp-up in Leqselvi and launch of Unloxcyt—HDFC Sec noted that increased investment spending of USD 100 million starting Q2FY26 and a 25 percent tax guidance were negatives. However, it maintained a positive outlook on India formulations and continued R&D spends (6–8 percent of sales), expecting a mid- to high-single-digit revenue growth trajectory and stable EBITDA expansion. JM Financial maintained a 'Buy' rating with a target price of ₹ 1,999. The brokerage termed Sun Pharma's Q1FY26 performance strong due to a better product mix and lower cost of goods sold. JM highlighted robust 14 percent YoY growth in India business and 17 percent growth in global specialty. While US generics remained under pressure, exports from Emerging Markets and ROW remained firm. The brokerage expects the new specialty launches, such as Leqselvi and Unloxcyt, alongside expansion of Ilumya and Winlevi, to drive the next leg of growth. Sun Pharma is projected to clock an 11 percent revenue CAGR over FY25–FY28, supported by a healthy cash balance of USD 3.5 billion and continued focus on oncology, ophthalmology, and dermatology. Motilal Oswal Financial Services reduced its target price to ₹ 1,960 from ₹ 2,000, while maintaining a 'Buy' call. The brokerage expects Sun Pharma's innovative and branded portfolio to continue providing earnings support, although it trimmed FY26 and FY27 EPS estimates by 5 percent and 4 percent respectively due to higher operating costs and tax outgo. It believes regulatory clarity on US tariffs remains a key monitorable but sees recent launches like Leqselvi and Ilumya pipeline filings boosting the company's specialty segment. It anticipates a 14 percent CAGR in earnings through FY27. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
40 minutes ago
- Time of India
JSW Energy shares rise 4% on strong Q1 results, renewable and thermal push gains
JSW Energy shares rose nearly 4% to Rs 533.6 in Friday's intraday trade on the BSE after the company posted a strong performance for the April–June quarter, with consolidated net profit jumping 42.4% year-on-year (YoY) to Rs 743 crore. The growth in Q1 was driven by a sharp scale-up in both renewable and thermal power generation . Revenue surged 78.6% YoY to Rs 5,143 crore, while EBITDA almost doubled to Rs 2,789 crore, reflecting a 96.8% increase. The operating margin expanded to 54.2% from 49.2% a year earlier. Explore courses from Top Institutes in Please select course: Select a Course Category CXO Design Thinking PGDM Degree Finance Management Digital Marketing Product Management Project Management healthcare Operations Management Data Analytics Public Policy Others Data Science Data Science Cybersecurity MBA MCA Leadership Healthcare others Technology Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details Skills you'll gain: Technology Strategy & Innovation Emerging Technologies & Digital Transformation Leadership in Technology Management Cybersecurity & Risk Management Duration: 24 Weeks Indian School of Business ISB Chief Technology Officer Starts on Jun 28, 2024 Get Details Skills you'll gain: Operations Strategy for Business Excellence Organizational Transformation Corporate Communication & Crisis Management Capstone Project Presentation Duration: 11 Months IIM Lucknow Chief Operations Officer Programme Starts on Jun 30, 2024 Get Details Skills you'll gain: Digital Strategy Development Expertise Emerging Technologies & Digital Trends Data-driven Decision Making Leadership in the Digital Age Duration: 40 Weeks Indian School of Business ISB Chief Digital Officer Starts on Jun 30, 2024 Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Seniors are going crazy for these comfy, stylish, easy-on shoes Ultra-Comfortable Shoes Undo During the quarter, the company commissioned 1,893 MW of capacity, taking its installed base to 12,768 MW — up 70% YoY. This includes 1,343 MW from the acquisition of Mytrah Energy (now O2 Power) and 550 MW through organic renewable additions. Total power generation rose 71% YoY to 13.5 billion units (BUs), with renewable generation contributing 5 BUs, up 54% YoY. Long-term PPA generation rose 73% to 11.8 BUs. Sharad Mahendra, Joint MD & CEO, called the quarter an 'inflexion point,' driven by disciplined investments, improved earnings quality, and capacity under long-term agreements. Live Events Thermal generation at the Vijayanagar plant surged 124% YoY, backed by new captive PPAs. JSW Energy also signed new PPAs totalling 605 MW during the quarter and 450 MW post-quarter. One unit of the Kutehr hydro project has been synchronised, with the rest expected to be commissioned soon. The company closed the quarter with 13 GW under construction and a total locked-in capacity of 30.3 GW. It aims to reach 30 GW of generation and 40 GWh of energy storage by FY2030. Also Read: Missed CDSL's 1,100% rally? NSDL IPO could be your second chance JSW Energy shares target price According to Trendlyne, the average target price for JSW Energy is Rs 588, suggesting a potential upside of 13%. Among 17 analysts tracking the stock, the consensus rating is 'Buy'. JSW Energy stock performance JSW Energy shares are down 28% in the past year but have gained 76% over the last two years and soared 1,034% over the past five years. The company's market capitalisation currently stands at Rs 91,111 crore. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Mint
an hour ago
- Mint
Suzlon Energy share price gains 5% on order book update, entry into F&O markets. Do you own?
Stock Market Today: Suzlon Energy share price gained 5% in the morning trade on Friday following its entry into the futures and options (F&O) segment and an order book update. Suzlon Energy, on Friday, August 1, informed the exchanges about the order from Zelestra India for its FDRE (Firm and Dispatchable Renewable Energy) project. FDRE projects refer to renewable energy projects, typically, that are integrated with energy storage systems (ESS) like batteries. Suzlon will power Zelestra India's first FDRE project with a 381 MW order across three states, said the company in a press release issued earlier today. The 381 MW project consists of 127 Suzlon S144 turbines spread over Maharashtra (180 MW), Madhya Pradesh (180 MW), and Tamil Nadu (21 MW). The project is part of SJVN's FDRE bid in Maharashtra and MP, with the Tamil Nadu portion serving commercial and industrial power consumers. Girish Tanti, Vice Chairman, Suzlon Group, in a statement, said that 'India's energy transition landscape is at a pivotal juncture, where the pursuit of reliable, round-the-clock renewable power (FDRE) is taking center stage. This project marks that critical shift." Another key trigger for Suzlon Energy was that the multibagger renewable energy stock entered the F&O trading segment. On the back of these updates, Suzlon Energy share price opened at ₹ 62.01 on the BSE on Friday. At the time of opening, Suzlon Energy share price was slightly higher compared to the previous day's closing price of ₹ 61.59. The stock extended gains further to an intraday high of ₹ 65.50, which meant gains of more than 6% during the intraday trade.
